Sign Up
av/revolution-medicines--big.svg

COM:REVMED

Revolution Medicines

  • Stock

Last Close

56.78

22/11 21:00

Market Cap

9.55B

Beta: -

Volume Today

1.17M

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.12
-
0.23
91.96%
0.08
66.62%
0.04
47.43%
0.04
9.42%
0.01
87.28%
cash conversion cycle
-2.38K
-
cash per share
0.25
-
1.91
666.45%
2.32
21.63%
8.03
246.13%
7.93
1.32%
8.00
0.92%
16.38
104.72%
company equity multiplier
3.33
-
1.76
46.96%
1.45
18.08%
1.20
17.32%
1.22
2.46%
1.18
3.25%
1.14
3.48%
days of inventory outstanding
days of payables outstanding
2.42K
-
days of sales outstanding
132.19
-
63.73
51.79%
54.29
14.81%
73.63
35.64%
48.21
34.53%
39.53
18.01%
dividend yield
ebit per revenue
-2.00
-
-1.08
45.92%
-2.58
138.13%
-6.40
148.39%
-7.30
14.12%
-42.07
476.31%
ebt per ebit
1.00
-
1.04
3.63%
0.96
7.21%
0.98
1.97%
1.00
1.50%
0.96
3.07%
0.90
6.39%
effective tax rate
-0.00
-
0.03
1,053.42%
0.08
161.29%
0.00
95.93%
0.04
1,044.55%
0.00
95.69%
0.01
375.18%
enterprise value multiple
-35.02
-
-24.67
29.56%
-31.13
26.16%
-19.37
37.77%
-9.57
50.59%
-7.32
23.54%
-5.52
24.61%
fixed asset turnover
2.93
-
7.00
138.61%
1.18
83.11%
0.41
65.12%
0.48
16.30%
0.12
75.87%
free cash flow per share
-0.73
-
-0.01
98.93%
-0.99
12,484.74%
-1.88
90.20%
-2.11
12.48%
-2.92
38.19%
-3.17
8.54%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
0.20
80.39%
interest coverage
-302.22
-
-347.66
15.04%
-510.57
46.86%
-1.56K
205.37%
-15.67K
904.89%
26.75
100.17%
-1.61K
6,111.18%
inventory turnover
long term debt to capitalization
0.02
-
0.01
50.48%
0.06
410.07%
0.09
58.32%
0.08
15.14%
0.04
45.36%
net income per ebt
1
-
1
0%
0.92
8.40%
1.00
8.80%
0.96
3.58%
1.00
3.90%
0.99
0.63%
net profit margin
-2.07
-
-0.95
54.04%
-2.52
164.18%
-6.12
143.08%
-7.03
14.92%
-37.68
436.06%
operating cash flow per share
-0.69
-
0.03
104.82%
-0.94
2,920.07%
-1.82
94.43%
-2.02
10.86%
-2.78
37.68%
-3.10
11.32%
operating cycle
39.53
-
operating profit margin
-2.00
-
-1.08
45.92%
-2.58
138.13%
-6.40
148.39%
-7.30
14.12%
-42.07
476.31%
payables turnover
0.15
-
pretax profit margin
-2.07
-
-1.04
49.82%
-2.52
142.81%
-6.37
152.12%
-7.04
10.61%
-37.99
439.48%
price fair value
232.64
-
10.91
95.31%
10.02
8.09%
4.58
54.34%
3.04
33.55%
2.80
7.84%
1.78
36.60%
receivables turnover
2.76
-
5.73
107.43%
6.72
17.39%
4.96
26.27%
7.57
52.74%
9.23
21.97%
return on assets
-2.06
-
-0.24
88.13%
-0.22
11.77%
-0.19
11.80%
-0.24
27.79%
-0.31
25.75%
-0.21
31.79%
return on capital employed
-4.16
-
-0.29
93.08%
-0.30
5.88%
-0.21
30.22%
-0.26
22.88%
-0.34
31.72%
-0.25
27.26%
return on equity
-6.87
-
-0.43
93.71%
-0.31
27.72%
-0.23
27.08%
-0.30
30.93%
-0.36
21.66%
-0.24
34.17%
total debt to capitalization
0.02
-
0.01
48.90%
0.06
419.80%
0.10
54.65%
0.09
13.95%
0.05
46.37%

All numbers in (except ratios and percentages)